Yanikoglu, R. Et Al. 2024. Development of Graphene Oxide-Based Anticancer Drug Combination Functionalized with Folic Acid as Nanocarrier for Targeted Delivery of Methotrexate. Pharmaceutics , vol.16, no.6 .

Yanikoglu, R., Karakas, C. Y., Ciftci, F., İNSEL, M. A., Karavelioglu, Z., Varol, R., ... Yilmaz, A.(2024). Development of Graphene Oxide-Based Anticancer Drug Combination Functionalized with Folic Acid as Nanocarrier for Targeted Delivery of Methotrexate. Pharmaceutics , vol.16, no.6.

Yanikoglu, Reyhan Et Al. "Development of Graphene Oxide-Based Anticancer Drug Combination Functionalized with Folic Acid as Nanocarrier for Targeted Delivery of Methotrexate," Pharmaceutics , vol.16, no.6, 2024

Yanikoglu, Reyhan Et Al. "Development of Graphene Oxide-Based Anticancer Drug Combination Functionalized with Folic Acid as Nanocarrier for Targeted Delivery of Methotrexate." Pharmaceutics , vol.16, no.6, 2024

Yanikoglu, R. Et Al. (2024) . "Development of Graphene Oxide-Based Anticancer Drug Combination Functionalized with Folic Acid as Nanocarrier for Targeted Delivery of Methotrexate." Pharmaceutics , vol.16, no.6.

@article{article, author={Reyhan Yanikoglu Et Al. }, title={Development of Graphene Oxide-Based Anticancer Drug Combination Functionalized with Folic Acid as Nanocarrier for Targeted Delivery of Methotrexate}, journal={Pharmaceutics}, year=2024}